Racial/Ethnic Disparities ID’d in Childhood Cancer Survival
Survival disparities decreased after adjustment for health insurance and area-level socioeconomic status.
Pediatric Cancer
Tool May Predict Risk of Subsequent Malignancies in Childhood Cancer Survivors
The tool proved most effective in survivors of solid tumors or central nervous system tumors and in patients not exposed to radiation during treatment of their primary malignancy.
Cisplatin-Induced Hearing Loss Up for Young Children With Cancer
The cumulative incidence of cisplatin-induced hearing loss was 75% in patients age 5 and younger, compared with 48% in older patients.
Children With Cancer Have Greater Risk of Severe COVID-19 Outcomes
About 20% of pediatric cancer patients who developed COVID-19 had severe or critical disease.
Genetic Ancestry Impacts Treatment Outcomes in Acute Lymphoblastic Leukemia
Researchers found a “strong genetic basis” for racial differences in survival.
Triplet Deemed New Standard Care for Relapsed or Refractory Rhabdomyosarcoma
Adding temozolomide to vincristine and irinotecan improved survival.
Real-World Data Show an Overall Decrease in Pediatric Melanoma Diagnoses in the United States
Researchers studied a total of 1903 cases of pediatric melanoma and patients were 54.4% female, the mean age was 12.4 years, and 89.8% were White.
Vorinostat Plus MIBG Proves More Effective Than Other MIBG Regimens in Relapsed or Refractory Neuroblastoma
Response rates were highest with MIBG plus vorinostat.
‘Excellent’ Outcomes and Room for Improvement in Pediatric Adrenocortical Carcinoma
Patients with stage II or IV disease did not fare as well as patients with stage I or III disease.
Sodium Thiosulfate Appears to Decrease Ototoxic Effects of Platinum Chemo Without Compromising Efficacy
More studies are needed to confirm if there is an effect on survival, according to researchers.
- Loading...
Loading...
Next post in General Oncology
Loading... 
Loading...